Until recently, clinicians have relied on the radiology report and the radiologist’s opinion with no way of accurately determining the extent of neurodegenerative diseases or ability to measure their progression over time. CorTechs.ai’s NeuroQuant® and LesionQuant™ address these issues.
Getz Healthcare has partnered with CorTechs.ai to bring these solutions to the Asia-Pacific region.
CorTechs.ai offers the most advanced artificial-intelligence-based methods for MR image analysis and delivers highly accurate and clinically relevant quantitative data for use in the diagnosis of brain diseases.
CorTechs.ai founder and co-creator of FreeSurfer, brain imaging software, Dr. Anders Dale, has created a culture of innovation with the purpose of improving the quality of patient care.
NeuroQuant® is the first and most widely used clinical solution for brain MRI quantification in the world. Scans support many of the most prominent radiologists and neurologists with highly accurate brain segmentation and volumetric data.
CorTechs.ai NeuroQuant® is used to aid in the accurate diagnosis, and effective treatment options for neurodegenerative conditions such as Alzheimer’s disease, epilepsy, multiple sclerosis, and brain trauma. CorTechs.ai NeuroQuant® analyses and produces five reports that assesses neurological atrophy.
CorTechs.ai has developed a dynamic brain atlas using thousands of healthy MRI scans, which NeuroQuant® uses to compare and report neurological abnormalities in patients that are matched based on sex and aged between 3 to 100 years old.
CorTechs.ai LesionQuant™ FLAIR report provides volumetric and quantitative information on lesions and four brain structure volumes. CorTechs.ai LesionQuant™ aids physicians in monitoring the disease progression of multiple sclerosis and other neurodegenerative diseases, enabling them to be better prepared to assess and treat these conditions.